Richard Katz, MD, MHA is a premier drug development consultant specializing in clinical trial-to-licensing transitions. With decades guiding biopharma through FDA/EMA approvals and global licensing, Dr. Katz transforms scientific innovation into commercial success across oncology, neurology, rare diseases, and digital therapeutics.